Beijing’s 2010 Biopharmaceutical Sales Reach RMB 55.95 Billion
This article was originally published in PharmAsia News
Executive Summary
Beijing's biopharmaceutical sales reached RMB 55.95 billion in 2010, RMB 48.35 billion for product sales and RMB 7.6 billion from R&D services, according to the recent Beijing Biopharmaceutical Industry Development Project (G20 Project)'s 2010 conference